SEC Form 4 · accession 0000891293-15-000049
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Plunkett
Officer — EVP, Corporate Development
Period of report
Sep 29, 2015
Accepted (ET)
Oct 1, 2015 · 6:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 29, 2015 | S | 52,306 | $1.41 | D | 672,778 | D | |
| Common Stock | Sep 29, 2015 | S | 5,108 | $1.4181 | D | 667,670 | D | |
| Common Stock | Sep 29, 2015 | S | 9,092 | $1.42 | D | 658,578 | D | |
| Common Stock | Sep 29, 2015 | S | 100 | $1.425 | D | 658,478 | D | |
| Common Stock | Sep 29, 2015 | S | 8,394 | $1.43 | D | 650,084 | D |
Table II — derivative securities
No Table II lines on this filing.